[Herpes zoster and post-herpetic neuralgia in the elderly: Particularities in prevention, diagnosis, and treatment]. / Herpes zoster (HZ) y neuralgia posherpética (NPH) en el adulto mayor: particularidades en la prevención, el diagnóstico y el tratamiento.
Gac Med Mex
; 153(1): 92-101, 2017.
Article
em Es
| MEDLINE
| ID: mdl-28128811
Herpes zoster (HZ) results from the reactivation of the varicella zoster virus latent in the sensory ganglia when cell-mediated immunity is altered. It is a frequent condition in older adults, leading to undesirable adverse outcomes. Aging is its main risk factor and the elderly may have different clinical presentations: zoster sine herpete, and a higher incidence of post-herpetic neuralgia (15%) and ophthalmic herpes (7%). Both HZ and post-herpetic neuralgia may impact the quality of life, functional status, mental health, and social interaction in older adults. Clinical trials have demonstrated that the vaccine decreases the incidence of HZ and post-herpetic neuralgia by up to 51% and 67%, respectively. When treating older adults with multi-morbidity, practitioners should consider starting low-dose drugs so they can look for potential drug-drug and drug-disease interactions. The aim of this article was to review the particularities of the risk factors, clinical presentation, complications, and treatment of HZ and post-herpetic neuralgia.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Neuralgia Pós-Herpética
/
Herpes Zoster
Tipo de estudo:
Diagnostic_studies
/
Etiology_studies
/
Risk_factors_studies
Aspecto:
Patient_preference
Limite:
Aged
/
Humans
Idioma:
Es
Revista:
Gac Med Mex
Ano de publicação:
2017
Tipo de documento:
Article
País de publicação:
México